Minims and malignant neoplasm progression Patient Reports February 13, 2012

Minims Side Effects Report #4987907-1
Minims side effect was reported by a Health Professional from UNITED KINGDOM on Apr 07, 2006. Male patient, 66 years of age, was diagnosed with t-cell lymphoma and was treated with Minims. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic function abnormal, malignant neoplasm progression, metastases to liver. Minims dosage: unknown. During the same period patient was treated with MABTHERA, VINCRISTINE, CYCLOPHOSPHAMIDE, ETOPOSIDE, GEMCITABINE, BLEOMYCIN, METHOTREXATE. Patient died.

Minims Side Effects Report #5405249-7
Minims side effect was reported by a Consumer or non-health professional from ARGENTINA on July 20, 2007. Male patient, 40 years of age, was diagnosed with hodgkin's disease  and was treated with Minims. After drug was administered, patient experienced the following side effects: coordination abnormal, csf test abnormal, febrile neutropenia, gait disturbance, headache , malignant neoplasm progression, metastasis, paraesthesia, paraparesis. Minims dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, BLEOMYCIN, CISPLATIN, CYCLOPHOSPHAMIDE, CYTARABINE, ETOPOSIDE, METHOTREXATE, PREDNISONE. Patient was hospitalized. Patient died.